Archives

by in
Entry Author Date Location
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share 02/13/14 Boston
Dicerna Shares Triple on First Trading Day, Close at $46 01/30/14 Boston
Dicerna Prices Upsized IPO at $15 Per Share, Starts Trading Thursday 01/29/14 Boston
Dicerna Joins Biotech IPO Queue, Plans $69M Raise 01/02/14 Boston
Radius Health Churns Through 3 CEOs, as Osteoporosis Drug Delayed 12/20/13 Boston
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
Zafgen Corrals $45M More to Fuel Obesity Drug Push 12/04/13 Boston
Zafgen Secures $45,000,000 Series E Financing Round 12/04/13 Boston
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
Dicerna Snags $60M as RNAi Heats Up Again 08/01/13 Boston
Dicerna Pharmaceuticals Obtains $60,000,000 Series C Funding 08/01/13 Boston
Radius Health CEO: Skin Patch Data is the Value Driver 05/13/13 Boston
East Coast Life Sciences Roundup: Bind, Gen9, Radius, Cydan 04/26/13 Boston
Radius Health Receives $43,000,000 New Round 04/26/13 Boston
Radius Health, Still Private, Raises Another $43M 04/25/13 Boston
Radius Health Seeks $86M IPO 02/07/12 Boston
Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing 05/24/11 Boston
Radius Health Obtains $91,000,000 New Funding 05/24/11 Boston
SS&C Prices IPO, Amag Gets $60M from Takeda, Selecta Nabs $15M, & More Boston-Area Deals News 04/07/10 Boston
$12M Series D for Brightcove 04/06/10 Boston
Brightcove Receives $12,000,000 Series D Financing 04/05/10 Boston
Reva Medical Regaining Ground in Development of Next-Generation Stent 05/05/09 San Diego
Blazent Garners $2,100,000 New Round 12/31/08 San Francisco
Buy-Side Experts See Major Changes Afoot for Biotech Amid Financial Crisis 10/30/08 National
Blazent Receives $3,000,000 New Financing 06/30/08 San Francisco
Concert Pharmaceuticals Garners $37,000,000 Series C Funding 04/30/08 Boston
Page 1 of 1